These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7533474)

  • 1. Prostatic specific antigen.
    el-Shirbiny AM
    Adv Clin Chem; 1994; 31():99-133. PubMed ID: 7533474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
    Oesterling JE
    J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen and prostatic acid phosphatase: biomolecular and physiologic characteristics.
    Bilhartz DL; Tindall DJ; Oesterling JE
    Urology; 1991 Aug; 38(2):95-102. PubMed ID: 1715106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen: biochemistry, analytical methods, and clinical application.
    Armbruster DA
    Clin Chem; 1993 Feb; 39(2):181-95. PubMed ID: 7679336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of prostate-specific antigen.
    Balk SP; Ko YJ; Bubley GJ
    J Clin Oncol; 2003 Jan; 21(2):383-91. PubMed ID: 12525533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
    Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
    Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
    Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
    Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR; Evans WP; Borden JD; Castellanos RD
    Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status of PSA determination for early detection of prostate carcinoma].
    Hammerer P; Huland H
    Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental carcinoma of the prostate.
    van Andel G; Vleeming R; Kurth K; de Reijke TM
    Semin Surg Oncol; 1995; 11(1):36-45. PubMed ID: 7538693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen: a valuable clinical tool.
    Oesterling JE
    Oncology (Williston Park); 1991 Apr; 5(4):107-22; discussion 122, 125-6, 128. PubMed ID: 1714288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
    Chen Z; Chen H; Stamey TA
    J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED; DeAntoni EP; Ross CA
    J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostate-specific antigen and digital rectal examination in the detection of prostate cancer.
    Yamamoto M; Hibi H; Miyake K
    Int J Urol; 1994 Mar; 1(1):74-7. PubMed ID: 7543009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PSA in the staging and monitoring of cancer of the prostate].
    Gil Sanz MJ; Sanz Velez JI; Liedana Torres JM; Roncales Badal AL; Allepuz Losa C; Rioja Sanz LA
    Actas Urol Esp; 1991; 15(6):527-31. PubMed ID: 1724347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate.
    Henttu P; Vihko P
    Ann Med; 1994 Jun; 26(3):157-64. PubMed ID: 7521173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.